eli lilly sues compounders for selling unapproved copies of tirzepatide Novo Nordisk filed a lawsuit against & Co. accusing the manufacturer weight-loss drug Zepbound of deceptive advertising allegedly comparing high doses of its drug to low doses of Eli Lilly's Popular Weight Loss
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 21 - Nov 26












:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)














